BDP1 encodes a subunit of transcription factor IIIB (TFIIIB), which is essential for RNA polymerase III transcription initiation. The protein functions as a general activator required for transcription from all three types of polymerase III promoters 1. Structurally, BDP1 shows similarities to RNA polymerase II factors TFIIA and TFIIF and plays a crucial role in the transition from closed to open pre-initiation complexes 1. The protein interacts with various transcriptional regulators, including ZNF297B, which may modulate its transcriptional activity 2. BDP1 is clinically significant as mutations cause autosomal recessive deafness (DFNB112). A specific mutation disrupting the termination codon and extending the protein by 11 residues has been identified in a Qatari family with hereditary hearing loss 3. Expression studies in mouse inner ear show Bdp1 localization in endothelial cells of the stria vascularis and mesenchyme-derived cells surrounding the cochlear duct 3. Additionally, BDP1 has potential as a biomarker in serous ovarian cancer, where altered expression correlates with disease stages and patient survival outcomes 4. The gene demonstrates significant genetic heterogeneity across populations, with different variants contributing to hearing impairment pathogenesis 5.